REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA

<span style="font-family: Times New Roman; font-size: small;"> </span><p style="margin: 0cm 0cm 10pt; text-align: justify; line-height: 200%;" class="MsoNormal"><span lang="EN-US" style="line-height: 200%;...

Full description

Saved in:
Bibliographic Details
Main Authors: Giovanni D'arena, Giovanni Rossi, Barbara Vannata, Silvia Deaglio
Format: Article
Language:English
Published: PAGEPress Publications 2012-01-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Online Access:http://www.mjhid.org/article/view/10576
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850283383414849536
author Giovanni D'arena
Giovanni Rossi
Barbara Vannata
Silvia Deaglio
author_facet Giovanni D'arena
Giovanni Rossi
Barbara Vannata
Silvia Deaglio
author_sort Giovanni D'arena
collection DOAJ
description <span style="font-family: Times New Roman; font-size: small;"> </span><p style="margin: 0cm 0cm 10pt; text-align: justify; line-height: 200%;" class="MsoNormal"><span lang="EN-US" style="line-height: 200%; font-family: "Times New Roman","serif"; font-size: 12pt; mso-ansi-language: EN-US; mso-bidi-font-size: 11.0pt;">Regulatory T-cells (Tregs) constitute a small subset of cells that are actively involved in maintaining self-tolerance, in immune homeostasis and in antitumor immunity. They are thought to play a significant role in the progression of cancer and are generally increased in patient with chronic lymphocytic leukemia (CLL). Their number correlates with more aggressive disease status and is predictive of the time to treatment, as well. Moreover, it is now clear that dysregulation in Tregs cell frequency and/or function may result in a plethora of autoimmune diseases, including multiple sclerosis, type 1 diabetes mellitus, myasthenia gravis, systemic lupus erythematosis, autoimmune lymphoproliferative disorders, rheumatoid arthritis, and psoriasis. Efforts are made aiming to develop approaches to deplete Tregs or inhibit their function in either cancer and autoimmune disorders. </span></p><span style="font-family: Times New Roman; font-size: small;"> </span>
format Article
id doaj-art-78bb005c43004da8926f58b741d24e01
institution OA Journals
issn 2035-3006
language English
publishDate 2012-01-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj-art-78bb005c43004da8926f58b741d24e012025-08-20T01:47:47ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062012-01-0141e2012053e2012053REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIAGiovanni D'arenaGiovanni RossiBarbara VannataSilvia Deaglio<span style="font-family: Times New Roman; font-size: small;"> </span><p style="margin: 0cm 0cm 10pt; text-align: justify; line-height: 200%;" class="MsoNormal"><span lang="EN-US" style="line-height: 200%; font-family: "Times New Roman","serif"; font-size: 12pt; mso-ansi-language: EN-US; mso-bidi-font-size: 11.0pt;">Regulatory T-cells (Tregs) constitute a small subset of cells that are actively involved in maintaining self-tolerance, in immune homeostasis and in antitumor immunity. They are thought to play a significant role in the progression of cancer and are generally increased in patient with chronic lymphocytic leukemia (CLL). Their number correlates with more aggressive disease status and is predictive of the time to treatment, as well. Moreover, it is now clear that dysregulation in Tregs cell frequency and/or function may result in a plethora of autoimmune diseases, including multiple sclerosis, type 1 diabetes mellitus, myasthenia gravis, systemic lupus erythematosis, autoimmune lymphoproliferative disorders, rheumatoid arthritis, and psoriasis. Efforts are made aiming to develop approaches to deplete Tregs or inhibit their function in either cancer and autoimmune disorders. </span></p><span style="font-family: Times New Roman; font-size: small;"> </span>http://www.mjhid.org/article/view/10576
spellingShingle Giovanni D'arena
Giovanni Rossi
Barbara Vannata
Silvia Deaglio
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Mediterranean Journal of Hematology and Infectious Diseases
title REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
title_full REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
title_fullStr REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
title_full_unstemmed REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
title_short REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
title_sort regulatory t cells in chronic lymphocytic leukemia
url http://www.mjhid.org/article/view/10576
work_keys_str_mv AT giovannidarena regulatorytcellsinchroniclymphocyticleukemia
AT giovannirossi regulatorytcellsinchroniclymphocyticleukemia
AT barbaravannata regulatorytcellsinchroniclymphocyticleukemia
AT silviadeaglio regulatorytcellsinchroniclymphocyticleukemia